In our experiment, baicalin was found to be effective in reducing the expression of TGF-β1 and phospho-ERK1/2 in pulmonary fibrosis, thus partially inhibiting epithelial mesenchymal transition (EMT), which may be a critical mechanism via which baicalin protects mice with PF. This evidence concerns the gene TGFB1 and pulmonary fibrosis.